| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |